Tell a Friend

Your Name :
Your Email :
Email To :
Comments :

PHRM 5601 Overview of Clinical Practice I (3 credits)

This course provides important information to IPBP students on topics such as the drug distribution system in the U.S., drug information, literature evaluation, biostatistics, the structure of the U.S. healthcare system, and healthcare issues in the USA. The purpose of building the knowledge base of the IPBP students is to be at par with their peers in the regular program. Additionally, introduction to patient counseling skills, the use of the objective, structured clinical examination (OSCE) in evaluation a student s clinical knowledge and skills, immunization certification, and self study on medical terminology further strengthens their foundation such that their knowledge, skills and attitudes are in concert with the regular PharmD program in terms of the overall provision of pharmaceutical care.

The curriculum begins with the first in a series of 3 1/2 week blocks that present topics and accompanying skills that lay the foundation for the practice of pharmacy. This first block provides an introduction to drug information, research methodology, and biostatistics in preparation for review and evaluating peer-reviewed clinical studies that are periodically assigned in this and the Pharmacy Practice blocks that follow. The block also introduces homeostasis, review anatomy, physiology, biochemistry, medical terminology, and laboratory interpretations or common procedures used in diagnosing patients. Students will continue to use these tools in subsequent blocks to evaluate therapeutic topics.

PHRM 6202 Pharmacy Practice II (4 credits)

Continuation of PHRM 6201. This block focuses on nutrition-related topics, but also covers fluids and electrolytes, renal physiology, and acid-base disorders. Accordingly, the overall goal of this block is to equip pharmacy students with elemental tools essential for providing pharmaceutical care as well as to integrate knowledge, skills, and attitudes to provide an individualized nutritional pharmacotherapeutic plan for a given patient.

PHRM 6203 Pharmacy Practice III (4 credits)

Continuation of PHRM 6202. This block focuses covers diseases affecting the gastrointestinal and the hepatobiliary systems. Specific emphasis is placed on the pharmacological treatment of peptic ulcer disease, inflammatory bowel disease, and alcoholic liver disease.

PHRM 6204 Pharmacy Practice IV (4 credits)

Continuation of PHRM 6203. Hypertension, diabetes and dyslipidemias are the focus of this block. These three major disease states exhibit comorbidity that can complicate pharmacotherapy. Emphasizing the treatment of these disease states allows the reintroduction of disease states covered in other blocks, thus allowing for the introduction of complicating factors and serves to improve students' critical thinking skills. Accompanying diagnostic procedures for these disease states allows the integration of content with further skills development. Block materials from previous blocks are reinforced throughout this block, and reinforcement of content from this block will occur in subsequent blocks.

PHRM 6205 Pharmacy Practice V (4 credits)

Continuation of PHRM 6204.This block is designed to allow the student an opportunity to strengthen their knowledge in the content areas previously covered in the second year blocks. Students will engage in team case discussions, which incorporate and integrate aspects of those disease states previously covered. In addition, students will continue to expand their knowledge of individual drug therapies by the construction of individual drug cards. Skills (e.g., counseling, patient education, calculation applications, drug information applications) relevant to the practice of pharmacy will be practiced in this block. Students will receive certification for the administration of immunizations. Prerequisite: PHRM 5113.

PHRM 6206 Pharmacy Practice VI (4 credits)

Continuation of PHRM 6205. This course covers pulmonary topics, including asthma (adult and pediatric) and chronic obstructive pulmonary disease (COPD). Students learn the proper use of inhalers, spacers, nebulizers and peak flow meters. This block also provides students with the knowledge, skills and attitudes to manage pharmacotherapeutic regimens in endocrine-related diseases, such as thyroid disorders and reproductive medicine. Gender-related health concerns are also addressed.

PHRM 6207 Pharmacy Practice VII (4 credits)

Continuation of PHRM 6206. This block contains epidemiology, anatomy, physiology, pharmacology, and pharmacotherapy as they relate to cardiovascular disease including arrhythmias, ischemic heart disease, heart failure, and thromboembolic diseases. Accordingly, the overall goal of this block is to enable students to integrate their knowledge of these topics in the context of formulating an individualized pharmacotherapeutic plan for a given patient with cardiac disease(s).

PHRM 6208 Pharmacy Practice VIII (4 credits)

Continuation of PHRM 6207. The purpose of this block is to enable students to integrate the pathophysiology, medicinal chemistry, pharmacology and therapeutic knowledge in the management of specific disease states. The content of the block will span psychiatric diseases, substance abuse and toxicological states. Students are provided the opportunity to practice clinical problem assessment and therapeutic drug monitoring in preparation for providing pharmaceutical care. Management of acute and chronic pain is also covered in this block. Certification in smoking cessation is provided in this block.

PHRM 6209 Pharmacy Practice IX (4 credits)

Continuation of PHRM 6208. This block focuses on the epidemiology, pathophysiology, pharmacology and pharmacotherapy relevant to diseases affecting the central nervous system, including dementias, epilepsy, headache, pain, parkinsonism, and stroke. The main goal of this block is to provide students with the fundamental knowledge, skills and attitudes required to provide optimal pharmaceutical care to patients with neurologic disorders.

PHRM 6210 Pharmacy Practice X (4 credits)

Continuation of PHRM 6209. This block is designed to allow the student an opportunity to strengthen their knowledge in the content areas previously covered in the second year blocks. Students will engage in team discussions, which incorporate and integrate aspects of those disease states previously covered. Skills (e.g., counseling, patient education, calculation applications, drug information applications) relevant to the practice of pharmacy will be practiced during this block. Students will receive instruction on the pharmacist's role in investigational drug services. The final examination comprehensively covers content material taken to this point.

This block is an extension of PHRM 6301 with a focus on special patient populations and opportunistic infections including fungal and viral infections. Pharmacology of antiviral and antifungal agents and the applications in treating infections will be discussed. The latter part of the block will focus on basic pharmacology of immunotherapeutic agents and their applications in transplantation.

PHRM 6303 Pharmacy Practice XIII (4 credits)

This block provides students an overview of pharmacy practice management in the community and hospital pharmacy settings. Students are familiarized with the conceptual underpinnings and applications of operations of pharmacy practice management, such as marketing, financial analysis, human resource management, purchasing and inventory control. Disease state management is emphasized as an important component of community pharmacy practice management. In the hospital setting, the importance of drug information, utilization review and clinical therapy guidelines and protocols is stressed.

PHRM 6304 Pharmacy Practice XIV (4 credits)

This block provides students with an understanding of the basic fundamentals of pharmacoeconomics (PE) and its value to decision making in health care. The block introduces students to the concepts and terminology associated with pharmacoeconomics including cost-of-illness, cost-minimization, cost-effectiveness, cost-benefit, cost-utility and decision analysis models. Other topics include an evaluation of the humanistic impact of drug therapy on quality-of-life outcomes, and use of sensitivity analyses in increasing the external validity of PE studies. Students will read and evaluate different types of PE studies published in the scientific literature. Student teams will be responsible for reading and analyzing selected PE literature and writing a comprehensive evaluation of each article using their knowledge of research methods, biostatistics and pharmacoeconomics

PHRM 6305 Pharmacy Practice XV (4 credits)

The objective of this block is to provide an introduction in the pathophysiology, medicinal chemistry, pharmacology, and therapeutic knowledge in the management of hematological disorders, hematological malignancies and solid tumors. Students will receive instruction in the following areas: appropriate cancer screening and prevention information to the general public; basic pharmacology of the commonly used antineoplastic agents in clinical settings; supportive care in oncology and patient specific treatments; and appropriate treatments for the common types of hematological disorders.

PHRM 6306 Pharmacy Practice XVI (4 credits)

This block is designed to allow the student an opportunity to strengthen their knowledge in the content areas previously covered in the second and third year blocks. Students will engage in team discussions, which incorporate and integrate aspects of those disease states previously covered. Skills (e.g., counseling, patient education, calculation applications, drug information applications, and skills associated with monitoring diseases) relevant to the practice of pharmacy will be practiced during this block. The block will end with a series of examinations covering content areas and skills learned and practiced during the previous blocks. Students must pass all examinations administered in this block before they will be allowed to proceed to the APPE.

Required Rotations

PHRM 7110 Ambulatory Care Externship (8 credits)

Supervised patient care experience in an outpatient setting under the supervision of a preceptor or faculty member of the College of Pharmacy.

PHRM 7120 Institutional Care Externship (8 credits)

Supervised patient care experience in a hospital or other institutional setting under the direct supervision of a preceptor or faculty member of the College of Pharmacy.

PHRM 7210 Ambulatory Care Clinical (8 credits)

Supervised clinical pharmacy experience emphasizing the development of pharmaceutical care skills in an out-patient setting.

PHRM 7220 Institutional Care Clinical (8 credits)

Supervised clinical pharmacy experience emphasizing the development of pharmaceutical care skills in a hospital or other institutional setting such as a long term care facility.

Supervised education in clinical, administrative or research settings that provide additional experience in specialty areas such as pediatrics, geriatrics, infectious disease, drug information, oncology, pharmaceutical research, pharmacy administration, etc.

PHRM 7340 Elective clerkship II (8 credits)

Supervised education in clinical, administrative or research settings that provide additional experience in specialty areas such as pediatrics, geriatrics, infectious disease, drug information, oncology, pharmaceutical research, pharmacy administration etc. Prerequisite: PHRM 7330.

PHRM 7350 Elective clerkship III (8 credits)

Supervised education in clinical, administrative or research settings that provide additional experience in specialty areas such as pediatrics, geriatrics, infectious disease, drug information, oncology, pharmaceutical research, pharmacy administration etc. Prerequisite: PHRM 7340.

Second Half, 4th Year Elective Coursework

After having successfully completed the APPE component of the curriculum, students are eligible to go on to their Advanced Electives. During the second half of the P-4 year, 16 credits of advanced elective coursework and 2 credits in the comprehensive review and assessment are required.

The 8000 series are designed for advanced elective coursework and the comprehensive assessment/review weeks. The advanced elective program is a capstone experience designed to prepare the student for his/her role as an entry level practitioner. Electives are offered in areas such as research, teaching, and advanced clinical practice. A project is required of each student. Finally, each student completes a required comprehensive two-week review and assessment at the end of the program.

PHRM 8200 Elective Coursework (4 credits)

Advanced level coursework in an area of special interest beyond that presented as part of the previous didactic coursework of the Doctor of Pharmacy Curriculum. Repeatable to a maximum of 16 credits.

PHRM 8400 Advanced Electives (16 credits)
Advanced clinical educational experiences in an area of special interest beyond that provided as part of the previous clinical coursework of the Doctor of Pharmacy Curriculum. Repeatable to a maximum of 16 credits.

PHRM 8600 Research Electives (16 credits)

Supervised participation in pharmacy related research under the direct supervision of a faculty member. Repeatable to a maximum of 16 credits.

PHRM 8800 Other Electives (4-16 credits)

Individualized, supervised educational experiences in an area of special interest related to pharmacy practice beyond that provided by previous coursework in the Doctor of Pharmacy curriculum and not eligible for credit within PHRM 8200, 8400 or 8600. Repeatable to a maximum of 16 credits.

PHRM 8999 Comprehensive Review and Assessment (2 credits)

A two week series of didactic and other educational experiences designed to provide students with a review of the Doctor of Pharmacy Curriculum and conduct assessments of the students competency for pharmacy practice.